Clinical pharmacology of leukotriene receptor antagonists and 5- lipoxygenase inhibitors

American Journal of Respiratory and Critical Care Medicine

Volumn 157, Issue 6 II SUPPL., 1998, Pages

  Drazen, Jeffrey ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

6 [[3 FLUORO 5 (3,4,5,6 TETRAHYDRO 4 METHOXY 2H PYRAN 4 YL)]PHENOXYMETHYL] 1 METHYL 2 QUINOLONE; ACETYLSALICYLIC ACID; BETA ADRENERGIC RECEPTOR STIMULATING AGENT; CORTICOSTEROID; LEUKOTRIENE B4; LEUKOTRIENE E4; LEUKOTRIENE RECEPTOR BLOCKING AGENT; LIPOXYGENASE INHIBITOR; PLACEBO; SALBUTAMOL; VERLUKAST; ZAFIRLUKAST; ZILEUTON;

ASTHMA; BRONCHUS HYPERREACTIVITY; CLINICAL PHARMACOLOGY; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; FORCED EXPIRATORY VOLUME; HUMAN; INFLAMMATION; LIVER TOXICITY; LUNG FUNCTION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; REVIEW; SYMPTOMATOLOGY;

EID: 0031798623     PISSN: 1073449X     EISSN: None     Source Type: Journal    
DOI: 10.1164/ajrccm.157.6.mar-5     Document Type: Review

References (18)

1. Israel, E., R. Dermarkarian, M. Rosenberg, R. Sperling, G. Taylor, P. Rubin, and J. M. Drazen. 1990. The effects of a 5-lipoxygenase inhibitor on asthma induced by cold, dry air. N. Engl. J. Med. 323:1740-1744.
2. Groen, H., H. L. Moesker, O. R. Leeuwenkamp, F. A. Sollie, and J. H. Jonkman. 1996. No pharmacokinetic or pharmacodynamic interaction between theophylline and the leukotriene biosynthesis inhibitor BAY X 1005. J. Clin. Pharmacol. 36:639-646.
3. 4 during aspirin-induced asthma. J. Lab. Clin. Med. 119:48-51.
4. Israel, E., A. R. Fischer, M. A. Rosenberg, C. M. Lilly, J. C. Callery, J. Shapiro, J. Cohn, P. Rubin, and J. M. Drazen. 1993. The pivotal role of 5-lipoxygenase products in the reaction of aspirin-sensitive asthmatics to aspirin. Am. Rev. Respir. Dis. 148:1447-1451.
5. Nasser, S. M. S., G. S. Bell, S. Foster, K. E. Spruce, R. MacMillan, A. J. Williams, T. H. Lee, and J. P. Arm. 1994. Effect of the 5-lipoxygenase inhibitor ZD2138 on aspirin-induced asthma. Thorax 49:749-756.
6. Dahlén, B., D. J. Margolskee, O. Zetterström, and S. E. Dahlén. 1993. Effect of the leukotriene receptor antagonist MK-0679 on baseline pulmonary function in aspirin sensitive asthmatic subjects. Thorax 48:1205-1210.
7. Israel, E., P. Rubin, J. P. Kemp, J. Grossman, W. Pierson, S. C. Siegel, D. Tinkelman, J. J. Murray, W. Busse, A. T. Segal, J. Fish, H. B. Kaiser, D. Ledford, S. Wenzel, R. Rosenthal, J. Cohn, C. Lanni, H. Pearl-man, P. Karahalios, and J. M. Drazen. 1993. The effect of inhibition of 5-lipoxygenase by zileuton in mild-to-moderate asthma. Ann. Intern. Med. 119:1059-1066.
8. 4 receptor antagonist, in subjects with bronchial asthma. Am. J. Respir. Crit. Care Med. 150:618-623.
9. Lockey, R. F., B. J. Lavins, and L. Snader. 1995. Effects of 13 weeks of treatment with ICI 204,219 (ACCOLATE) in patients with mild to moderate asthma (abstract). J. Allergy Clin. Immunol. 95:350.
10. Fish, J. E., J. P. Kemp, R. F. Lockey, M. Glass, L. A. Hanby, C. M. Bonuccelli, and the Zafirlukast Trialists Group. 1997. Zaftrlukast for symptomatic mild-to-moderate asthma: a 13-week multicenter study. Clin. Ther. 19:675-690.
11. Drazen, J. M., E. Israel, H. A. Boushey, V. M. Chinchilli, J. V. Fahy, J. E. Fish, S. C. Lazarus, R. J. Martin, S. P. Peters, C. Sorkness, and S. J. Szefler. 1996. Comparison of regularly scheduled with as-needed use of albuterol in mild asthma. N. Eng. J. Med. 335:841-847.
12. Suissa, S., R. Dennis, P. Ernst, O. Sheehy, and S. Wood-Dauphinee. 1997. Effectiveness of the leukotriene receptor antagonist zafirlukast for mild-to-moderate asthma: a randomized, double-blind, placebo-controlled trial. Ann. Intern. Med. 126:177-183.
13. Israel, E., J. Cohn, L. Dubé, J. M. Drazen, and the Zileuton Clinical Trial Group. 1996. Effect of treatment with zileuton, a 5-lipoxygenase inhibitor, in patients with asthma: a randomized controlled trial. J.A.M.A. 275:931-936.
14. Liu, M. C., L. M. Dube, and J. Lancaster. 1996. Acute and chronic effects of a 5-lipoxygenase inhibitor in asthma: a 6-month randomized multicenter trial. J. Allergy Clin. Immunol. 98(Pt. 1):859-871.
15. Wenzel, S. E., J. B. Trudeau, D. A. Kaminsky, J. Cohn, R. J. Martin, and J. Y. Westcott. 1995. Effect of 5-lipoxygenase inhibition on bronchoconstriction and airway inflammation in nocturnal asthma. Am. J. Respir. Crit. Care Med. 152:897-905.
16. Rosenthal, R., B. J. Lavins, and L. A. Hanby. 1996. Effect of treatment with zafirlukast (Accolate) on bronchial hyperresponsiveness in patients with mild-to-moderate asthma. J. Allergy Clin. Immunol. 97:250.
17. Kraan, J., G. H. Koeter, Th. W. Van der Mark, M. Boorsma, J. Kukler, H. J. Sluiter, and K. De Vries. 1988. Dosage and time effects of inhaled budesonide on bronchial hyperreactivity. Am. Rev. Respir. Dis. 137:44-48.
18. Woolcock, A. J., and C. R. Jenkins. 1990. Assessment of bronchial responsiveness as a guide to prognosis and therapy in asthma. Med. Clin. N. Am. 74:753-765.